Cargando…
Biodistribution and Pharmacokinetics Study of siRNA-loaded Anti-NTSR1-mAb-functionalized Novel Hybrid Nanoparticles in a Metastatic Orthotopic Murine Lung Cancer Model
Small interfering RNA (siRNA) is effective in silencing critical molecular pathways in cancer. The use of this tool as a treatment modality is limited by lack of an intelligent carrier system to enhance the preferential delivery of this molecule to specific targets in vivo. In the present study, the...
Autores principales: | Perepelyuk, Maryna, Thangavel, Chellappagounder, Liu, Yi, Den, Robert B, Lu, Bo, Snook, Adam E, Shoyele, Sunday A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012553/ https://www.ncbi.nlm.nih.gov/pubmed/26812654 http://dx.doi.org/10.1038/mtna.2015.56 |
Ejemplares similares
-
siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer
por: Perepelyuk, Maryna, et al.
Publicado: (2017) -
Novel targeted siRNA-loaded hybrid nanoparticles: preparation, characterization and in vitro evaluation
por: Dim, Nneka, et al.
Publicado: (2015) -
Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins
por: Perepelyuk, Maryna, et al.
Publicado: (2016) -
Bone Health Management in the Continuum of Prostate Cancer Disease
por: Boopathi, Ettickan, et al.
Publicado: (2022) -
Increased Brain Neurotensin and NTSR2 Lead to Weak Nociception in NTSR3/Sortilin Knockout Mice
por: Devader, Christelle, et al.
Publicado: (2016)